Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Safe and effective.

× No keyword cloud information.

5 in total

1. Molecular biology of pharmacologic vitreolysis.

Authors: J Sebag
Journal: Trans Am Ophthalmol Soc Date: 2005

2. Comparing outcomes in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration treated with two different doses of primary intravitreal bevacizumab: results of the Pan-American Collaborative Retina Study Group (PACORES) at the 12-month follow-up.

Authors: Lihteh Wu; J Fernando Arevalo; Mauricio Maia; Maria H Berrocal; Juan Sanchez; Teodoro Evans
Journal: Jpn J Ophthalmol Date: 2009-03-31 Impact factor: 2.447

Review 3. [(Side) effects of VEGF inhibition].

Authors: F Ziemssen; K U Bartz-Schmidt; S Grisanti
Journal: Ophthalmologe Date: 2006-06 Impact factor: 1.059

4. Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation.

Authors: Sandra Joeres; Florian M A Heussen; Tobias Treziak; Silvia Bopp; Antonia M Joussen
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2007-04-17 Impact factor: 3.117

5. Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up.

Authors: J Fernando Arevalo; Juan G Sanchez; Jans Fromow-Guerra; Lihteh Wu; Maria H Berrocal; Michel E Farah; Jose Cardillo; Francisco J Rodríguez
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2009-02-03 Impact factor: 3.117

5 in total